Projects per year
Personal profile
Biography
Her focus is on developing practical and affordable vaccines and treatments for complex diseases like malaria and cancer. She has also pioneered the use of synthetic size-defined non-inflammatory nanoparticles in vaccines.
Magdalena has forged a stellar career in medical and health research. She came to Australia from Oxford University in the UK, where she showed new ways in which malaria parasites can trick the human immune system. More recently, her insights have been used to help understand cancer progression across multiple human clinical trials, particularly leukemia and ovarian cancer.
Her nanoparticle studies also opened the door to new nanotechnology applications to prevent allergic airways disease. She has more than 50 patents in 10 patent families, which have supported the formation of biotechnology companies.
Magdalena has published more than 150 peer-reviewed full-length papers, including in leading journals such as Lancet, Nature, Science, Immunity, Nature Biotechnology, Nature Medicine and Nature Communications among others, and has secured funding from national and international grant bodies, as well as charitable and commercial funding.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Research area keywords
- Malaria
- Cancer
- Nanoparticles
- Immunology
- Allergic airways disease
Collaborations and top research areas from the last five years
-
Multiplex Active Ration Test for the Detection of Early Stage Ovarian Cancer
Stephens, A. (Primary Chief Investigator (PCI)) & Plebanski, M. (Chief Investigator (CI))
1/07/18 → 30/06/21
Project: Research
-
NHMRC equipment grant - BD LSR Fortessa X20 Flow Cytometry system
Tarlinton, D. (Primary Chief Investigator (PCI)), O'Hehir, R. (Chief Investigator (CI)), Cooper, M. (Chief Investigator (CI)), Peleg, A. (Chief Investigator (CI)), Curtis, D. (Chief Investigator (CI)), Dickins, R. (Chief Investigator (CI)), van Zelm, M. (Chief Investigator (CI)), Plebanski, M. (Chief Investigator (CI)), Spencer, A. (Chief Investigator (CI)), Hibbs, M. (Chief Investigator (CI)), Wei, A. (Chief Investigator (CI)), Guthridge, M. A. (Chief Investigator (CI)) & Thomas, M. (Chief Investigator (CI))
1/12/16 → 31/12/16
Project: Research
-
NHMRC Equipment Grant - Amnis ImageStreamX Mark II Imaging Flow Cytometer (Mark II)
Tarlinton, D. (Primary Chief Investigator (PCI)), Curtis, D. (Chief Investigator (CI)), Guthridge, M. A. (Chief Investigator (CI)), Jane, S. (Chief Investigator (CI)), Medcalf, R. (Chief Investigator (CI)), O'Hehir, R. (Chief Investigator (CI)), Plebanski, M. (Chief Investigator (CI)), Ting, S. (Chief Investigator (CI)) & van Zelm, M. (Chief Investigator (CI))
National Health and Medical Research Council (NHMRC) (Australia)
1/12/15 → 31/12/15
Project: Research
-
TBV: Transmission-blocking vaccine (TBV) for malaria
Plebanski, M. (Chief Investigator (CI)), Dinglasan, R. (Primary Chief Investigator (PCI)) & Hai-Quan, M. (Chief Investigator (CI))
4/03/15 → 3/03/20
Project: Research
-
Immunity and Ovarian Cancer
Plebanski, M. (Primary Chief Investigator (PCI)) & Quinn, M. A. (Chief Investigator (CI))
Australia New Zealand Gynaecological Oncology Group (trading as Women's Cancer Foundation)
30/10/13 → 30/10/16
Project: Research
-
Bionano Interactions of Organosilica Nanoparticles with Myeloid Derived Immune Cells
Henderson, E., Wilson, K., Huynh, G., Plebanski, M. & Corrie, S., 7 Aug 2024, In: ACS Applied Materials and Interfaces. 16, 33, p. 43329-43340 12 p.Research output: Contribution to journal › Article › Research › peer-review
-
Carnosine Supplementation Has No Effect on Inflammatory Markers in Adults with Prediabetes and Type 2 Diabetes: A Randomised Controlled Trial
Saadati, S. (Leading Author), de Courten, M., Deceneux, C., Plebanski, M., Scott, D., Mesinovic, J., Jansons, P., Aldini, G., Cameron, J., Feehan, J., Mousa, A. (Leading Author) & de Courten, B. (Leading Author), Nov 2024, In: Nutrients. 16, 22, 13 p., 3900.Research output: Contribution to journal › Article › Research › peer-review
Open Access2 Citations (Scopus) -
Combining TNFR2-Expressing Tregs and IL-6 as Superior Diagnostic Biomarkers for High-Grade Serous Ovarian Cancer Masses
Kampan, N. C., Kartikasari, A. E. R., Deceneux, C., Madondo, M. T., McNally, O. M., Flanagan, K. L., Aziz, N. A., Stephens, A. N., Reynolds, J., Quinn, M. A. & Plebanski, M., Feb 2023, In: Cancers. 15, 3, 20 p., 667.Research output: Contribution to journal › Article › Research › peer-review
Open Access5 Citations (Scopus) -
Extensive genome analysis identifies novel plasmid families in Clostridium perfringens
Gulliver, E. L., Adams, V., Marcelino, V. R., Gould, J., Rutten, E. L., Powell, D. R., Young, R. B., D'Adamo, G. L., Hemphill, J., Solari, S. M., Revitt-Mills, S. A., Munn, S., Jirapanjawat, T., Greening, C., Boer, J. C., Flanagan, K. L., Kaldhusdal, M., Plebanski, M., Gibney, K. B. & Moore, R. J. & 2 others, , 1 Apr 2023, In: Microbial Genomics. 9, 4, 16 p., 000995.Research output: Contribution to journal › Article › Research › peer-review
Open Access9 Citations (Scopus) -
Modeling COVID-19 disease processes by remote elicitation of causal Bayesian networks from medical experts
COVID BN Advisory Group, Dec 2023, In: BMC Medical Research Methodology. 23, 1, 21 p., 76.Research output: Contribution to journal › Article › Research › peer-review
Open AccessFile5 Citations (Scopus)